ATE338541T1 - Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien - Google Patents
Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämienInfo
- Publication number
- ATE338541T1 ATE338541T1 AT00973114T AT00973114T ATE338541T1 AT E338541 T1 ATE338541 T1 AT E338541T1 AT 00973114 T AT00973114 T AT 00973114T AT 00973114 T AT00973114 T AT 00973114T AT E338541 T1 ATE338541 T1 AT E338541T1
- Authority
- AT
- Austria
- Prior art keywords
- labdan
- leukemia
- tumors
- treatment
- formulations containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR99100387 | 1999-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338541T1 true ATE338541T1 (de) | 2006-09-15 |
Family
ID=32448784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00973114T ATE338541T1 (de) | 1999-11-08 | 2000-11-08 | Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien |
Country Status (3)
| Country | Link |
|---|---|
| AT (1) | ATE338541T1 (de) |
| AU (1) | AU773462B2 (de) |
| DE (1) | DE60030593D1 (de) |
-
2000
- 2000-11-08 AU AU11662/01A patent/AU773462B2/en not_active Ceased
- 2000-11-08 AT AT00973114T patent/ATE338541T1/de not_active IP Right Cessation
- 2000-11-08 DE DE60030593T patent/DE60030593D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU773462B2 (en) | 2004-05-27 |
| AU1166201A (en) | 2001-06-06 |
| DE60030593D1 (de) | 2006-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE447947T1 (de) | Pharmazeutische zubereitungen zur behandlung von insulinresitenz | |
| ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
| EP1274444A4 (de) | Arzneistoffe zur behandlung psychiatrischer oder abusus-bedingter störungen | |
| DE60142473D1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| ATE320257T1 (de) | (s,s)-reboxetine zur behandlung chronischer schmerzen | |
| ATE235481T1 (de) | Substituierte benzopyranderivate zur behandlung von entzündungen | |
| EP0709090A3 (de) | Zusammensetzungen zur Behandlung von resistenten Tumoren | |
| DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
| DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| ATE265857T1 (de) | Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| ATE292134T1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| DE60030554T8 (de) | Verwendungen von et743 zur behandlung von krebs | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| ATE414512T1 (de) | Kombinationstherapie zur behandlung von krebs | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| DE69737067D1 (de) | Vakzine zur behandlung von mycosen | |
| DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
| DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |